Atlas Trials

A Research Trial of Aralast in New Onset Diabetes (RETAIN)

Clinical trial NCT01183468 · TERMINATED

Trial details

NCT number
NCT01183468
Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Diabetes Mellitus, Type 1
Start date
2010-10-01
Primary completion
2013-07-01
Enrollment
17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.